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Abstract
Background:  Staphylococcus  genus is widely spread in nature being part of the indigenous
microbiota of skin and mucosa of animal and birds. Some Staphylococcus species are frequently
recognized as etiological agents of many animal and human opportunistic infections This is the first
report testing the antibiotic resistance-modifying activity of Turnera ulmifolia against methicillin-
resistant Staphylococcus aureus – MRSA strain.
Methods: In this study an ethanol extract of Turnera ulmifolia L. and chlorpromazine were tested
for their antimicrobial activity alone or in combination with aminoglycosides against an MRSA
strain.
Results:  The synergism of the ethanol extract and aminoglycosides were verified using
microdillution method. A synergistic effect of this extract on gentamicin and kanamycin was
demonstrated. Similarly, a potentiating effect of chlorpromazine on kanamycin, gentamicin and
neomycin, indicating the involvement of an efflux system in the resistance to these aminoglycosides.
Conclusion: It is therefore suggested that extracts from Turnera ulmifolia could be used as a source
of plant-derived natural products with resistance-modifying activity, constituting a new weapon
against the problem of bacterial resistance to antibiotics demonstrated in MRSA strains.
Background
Staphylococcus genus is widely spread in nature being part
of the indigenous microbiota of skin and mucosa of ani-
mal and birds. Some Staphylococcus species are frequently
recognized as etiological agents of many animal and
human opportunistic infections [1]. S. aureus, S. epider-
midis, S. saprophyticus and  S. haemolyticus are the most
important species as community and nosocomial human
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infection causing agents. In addition of causing different
kinds of intoxications, S. aureus has been the most com-
mon etiological agent of festering infections that attack
different tissues and/or organs (e.g. furuncle, carbuncle,
abscess, myocarditis, endocarditis, pneumonia, meningi-
tis, bacterial arthritis) [2,3]. Capsule, peptidoglican, tei-
coic acids, adesins and synthesis of enzymes and
extracelullar toxins are some virulence attributes present
in/on S. aureus cell [1].
Clinicians write millions prescriptions for antimicrobials
every year [4]. Clinicians need to apply sound concepts
when prescribing antimicrobials to both achieve a good
outcome and avoid encouraging resistance. There is con-
vincing evidence that inappropriate use of antibiotics
directly leads to the development of resistant organisms
[5]. To prevent this, is necessary educate all health worker
regarding healthy drug use and regarding the natural his-
tory of the infection, emphasizing palliative therapies and
infection control measures [6]. Infectious diseases are the
major cause of morbidity and mortality and experience
has shown that an approach that seeks to 'defeat' infec-
tious diseases will not work. Long-term solutions must
acknowledge this, and nurses and other health care pro-
fessionals must take a proactive part in finding alternative
solutions [7].
With increased incidence of resistance to antibiotics, nat-
ural products from plants could be interesting alternatives
[8,9]. Some plant extracts and phytochemicals are known
to have antimicrobial properties, and can be of great sig-
nificance in therapeutic treatments. In the last few years, a
number of studies have been conducted in different coun-
tries to demonstrate such efficacy [10-12].
Many plants have been evaluated not only for direct anti-
microbial activity, but also as a resistance-modifying
agent [13]. Several chemical compounds, synthetic or
from natural sources, such as the phenothiazines, and nat-
ural products, have direct activity against many species of
bacteria, enhancing the activity of a specific antibiotic,
reversing the natural resistance of specific bacteria to given
antibiotics, promoting the elimination of plasmids from
bacteria and inhibiting transport functions of the plasma
membrane in regard to given antibiotics. The inhibition
of plasma membrane-based efflux pumps has been
observed as well [14,15]. The enhancement of antibiotic
activity or the reversal of antibiotic resistance by natural or
synthetic non-conventional antibiotics affords the classifi-
cation of these compounds as modifiers of antibiotic
activity.
Turnera ulmifolia L. (Turneraceae), a small annual herb,
can be found in the north and northeast brazilian regions,
where it is considered a weed [16]. It grows preferentially
in sandy soils and on hill slopes. T. ulmifolia L. is already
known to be of medicinal value, being used popularly as
an anti-inflammatory, as an expectorant, and in the treat-
ment of several problems [16-18]. Authors detected flavo-
noids, alkaloids, tannins and phenolic compounds in
preparations from this plant [19-21].
Aminoglycosides are potent bactericidal antibiotics target-
ing the bacterial ribosome, and the increase in cases of
bacterial resistance to aminoglycosides is widely recog-
nized as a serious health threat [22]. The main mecha-
nisms of resistance to aminoglycosides are active efflux
and enzymatic inactivation [23].
In this work, we tested an ethanol extract of Turnera ulmi-
folia as a resistance modifying agent in an aminoglyco-
side-resistant strain of S. aureus.
Methods
Strains
The strain used was the clinical isolate Staphylococcus
aureus 358 (SA358), resistant to several aminoglycosides
[24]. The SA-ATCC25923 strain of Staphylococcus aureus
was used as a positive control. The strains were main-
tained in heart infusion agar slants (HIA, Difco), and prior
to assay, the cells were grown overnight at 37°C in brain
heart infusion (BHI, Difco).
Plant material
Leaves of Turnera ulmifolia were collected in the county of
Crato, Ceará State, Brazil. The plant material was identi-
fied and a voucher specimen was deposited with the
number 1618 at the Herbarium "Dárdano de Andrade
Lima" of Universidade Regional do Cariri – URCA.
Preparation of ethanol extract of Turnera ulmifolia 
(EETU)
A quantity of 200 g of leaves were dried at room tempera-
ture and powdered. The powdered material was extracted
by maceration using 1 L of 95% ethanol as solvent at
room temperature, and the homogenate was allowed to
stand for 72 h at room temperature. The extracts were then
filtered and concentrated under vacuum in a rotary evap-
orator [25]. For the tests, the dry extract material was dis-
solved in DMSO (dimethyl sulfoxide) 0,5%. The DMSO
was chosen due its less toxicity than ethanol.
Drugs
Chlorpromazine, gentamicin, tobramycin, kanamycin,
amikacin and neomycin were obtained from Sigma
Chemical Co. All drugs were dissolved in sterile water.
Drug susceptibility test
The minimum inhibitory concentration (MIC) of EETU,
antibiotics and chlorpromazine (CPZ) were determinedBMC Complementary and Alternative Medicine 2009, 9:13 http://www.biomedcentral.com/1472-6882/9/13
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in BHI by the microdilution assay using suspensions of
105 CFU/ml and a drug concentration range of 1024 to 1
μg/ml (twofold serial dilutions) [26]. MIC was defined as
the lowest concentration at which no growth was
observed. For the evaluation of EETU as a modulator of
antibiotic resistance, MICs of the antibiotics were deter-
mined in the presence of EETU (32 μg/ml) and CPZ (16
μg/ml) at sub-inhibitory concentrations, and the plates
were incubated for 24 h at 37°C. CPZ was used as positive
control for efflux pump inhibition [27]. Each experiment
was undertaken in duplicate.
Results
The EETU did not show a substantial antibacterial activity
at 1024 μg/ml against the strains assayed (MIC ≥ 1024 μg/
ml). None effect was observed when EETU was combined
with the aminoglycosides in the strain SA-ATCC25923.
The addiction of EETU to the growth medium at 32 μg/ml
produced a dramatic reduction in the MIC for gentamicin
and kanamycin in the strain Staphylococcus aureus 358,
demonstrating a potentiating effect of EETU on aminogly-
coside activity (Table 1).
A MIC reduction for gentamicin and kanamycin was also
observed when CPZ was added to the growth medium at
16 μg/ml, which indicates the involvement of an efflux
pump in the resistance to these antibiotics (Table 1).
A potentiating effect of CPZ on amikacin and tobramycin
was not observed, which suggests the occurrence of other
resistance mechanisms (Table 1).
Discussion
Only few articles were published focusing pharmacologi-
cal activities of the genus Turnera. Some species of Turnera
are widely used in folk medicine for different types of
inflammatory diseases. Fresh leaves of T. guaianensis Aubl.
is used to treat inflammatory diseases in general and as an
immunomodulator while the decoction of it's dried leaves
is employed to treat furunculosis [17]. T. diffusa Willd., in
a decoction of the whole plant, is used to treat otitis and
nephritis [28,29], while the leaf infusion is used in dis-
eases related to the gastrointestinal and respiratory sys-
tems [30], reproductive organs in general or specifically
for gonorrhoea treatment [17]. T. ulmifolia is used popu-
larly as an anti-inflammatory and as an expectorant [16-
18], but as far as we know, natural products of Turnera
ulmifolia or of any plants from the genus Turnera having a
potentiating effect on any drug, mainly antibiotics (as
aminoglycosides) have not been previously reported in
human or animals.
Phenothiazines, such as chlorpromazine, probably act on
the plasma membrane of bacteria affecting the efflux
pumps [31]. This modification of permeability could
enhance the activity of antibiotics that act within the cell,
such as the aminoglycosides.
Efflux pumps have been associated with resistance mech-
anisms since the 1980s32, representing one of the main
mechanism of multidrug resistance (MDR) evolved in the
antibiotic resistance to aminoglycosides [32]. Several
studies have been performed to identify drugs interfering
with these pumps, called resistance modifying agents
[33]. Other plant products, as ethanol extract of Mentha
arvensis, affected the efflux system of an Escherichia coli
multiresistant to aminoglycosides, inhibitinh these resist-
ance mechanism [27].
This strategy is named "herbal shotgun" or "Synergistic
multi-target effects" and refers to the use of herbals and
drugs in a multitargeted approach, due the fact of mono
or multi-extract combinations affect not only a single tar-
get, but several ones, cooperating in an agonistic-synergis-
tic way. This approach are not exclusive for extract
combinations, but combinations between single natural
products or extracts with chemosynthetics or antibiotics
are possible too [34,35].
Conclusion
The results obtained indicate that Turnera ulmifolia (and
broadly Turneraceae) could serve as a source of plant-
derived natural products with antibiotic resistance-modi-
fying activity to be used against multiresistant bacteria as
MRSA strains acquired from hospital and community.
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